Abstract
Background
In the past years, chemoresistance greatly limited the clinical therapeutic efficiency of oxaliplatin (OXA) in gastric cancer (GC). γ-Tocotrienol (γ-T3), a subtype of vitamin E, has attracted a lot of attention on monotherapies or with traditional chemotherapeutic agents. Therefore, the co-treatment of γ-T3 with OXA could be an excellent measure to combat this problem.
Methods
This study investigated the effects of γ-T3 combined with oxaliplatin (OXA) on the proliferation, cell cycle, autophagy, and ARHGAP29/GSK-3β/β-Catenin signaling pathways in gastric cancer cells, employing methods such as MTT and MB assays, flow cytometry, Western blot, real-time quantitative PCR, immunohistochemistry, and molecular docking, as well as in vivo assessment using a nude mouse xenograft model to evaluate the synergistic antitumor effects of γ-T3 and OXA.
Results
In this study, we found that treatment of γ-T3 with OXA inhibited the proliferation and arrested the cell cycle of MKN45 cells and AGS cells, especially better synergistic effects could be gotten in combination of γ-T3 (26.3µmol/L) and OXA (600nmol/L) in MKN45 cells (CI = 0.55). Compared to the control group (30% alcohol), nude mice injected with γ-T3 (20mg/kg b.w.) or OXA (2.0 mg/kg b.w) by intraperitoneal (IP) suppressed the growth of MKN45 cell xenografts, and the efficacy was significantly augmented by co-treatment of γ-T3 and OXA. In addition, ARHGAP29 was negatively correlated with the prognosis of gastric cancer and exhibited binding activity to γ-T3. Combination treatment with γ-T3 and OXA specially down-regulated ARHGAP29 expression in MKN45 cells and xenografts, and then further inhibited downstream GSK-3β/β-Catenin signaling by autophagy induced, resulting from increased LC3-Ⅰ/LC3-Ⅱ ratio and Beclin1 expression, and decreased p62 expression. Overexpression of ARHGAP29 reversed the autophagy-induced decrease in the cell viability of MKN45 cells via a GSK-3β/β-Catenin signaling.
Conclusions
Our findings indicated that γ-T3 exerts a synergistic effect of OXA on inducting autophagy and inhibiting the progression of GC, partially via ARHGAP29/GSK-3β/β-Catenin pathways.